Cargando…

Post-marketing safety surveillance conducted in Korea (2008–2013) following the introduction of the rotavirus vaccine, RIX4414 (Rotarix™)

Purpose: According to regulations from the Ministry of Food and Drug Safety in Korea, additional safety information on the use of Rotarix™ vaccine (RIX4414; GSK, Belgium) in ≥3000 evaluable Korean infants was required following vaccine registration. In order to comply with these regulations, we cond...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Son Moon, Kim, Chun Soo, Karkada, Naveen, Liu, Aixue, Jayadeva, Girish, Han, Htay Htay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2016
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084987/ https://www.ncbi.nlm.nih.gov/pubmed/27494163 http://dx.doi.org/10.1080/21645515.2016.1189046

Ejemplares similares

Pharmacoeconomic Spotlight on Rotavirus Vaccine RIX4414 (Rotarix™) in Developed Countries
por: Plosker, Greg L.
Publicado: (2012)

Serologic response to porcine circovirus type 1 (PCV1) in infants vaccinated with the human rotavirus vaccine, Rotarix™: A retrospective laboratory analysis
por: Han, Htay Htay, et al.
Publicado: (2016)

Early exposure of infants to natural rotavirus infection: a review of studies with human rotavirus vaccine RIX4414
por: Cunliffe, Nigel, et al.
Publicado: (2014)

Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: A randomized, placebo-controlled trial in China
por: Li, Rong-cheng, et al.
Publicado: (2014)

The human rotavirus vaccine Rotarix™ in infants: An integrated analysis of safety and reactogenicity
por: Buyse, Hubert, et al.
Publicado: (2014)

Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China: Randomized, double-blind, placebo-controlled Phase I studies
por: Li, Rong-Cheng, et al.
Publicado: (2013)

Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infants
por: Li, Rong-cheng, et al.
Publicado: (2015)

Reactogenicity and safety of the human rotavirus vaccine, Rotarix™ in The Philippines, Sri Lanka, and India: A post-marketing surveillance study
por: Bravo, Lulu, et al.
Publicado: (2014)

Will vaccination against rotavirus infection with RIX4414 be cost-saving in Germany?
por: Knoll, Stefanie, et al.
Publicado: (2013)

T7 expression plasmids for producing a recombinant human G1P[8] rotavirus comprising RIX4414 sequences of the RV1 (Rotarix , GSK) vaccine strain
por: Philip, Asha A., et al.
Publicado: (2023)

Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis
por: Rose, Johnie, et al.
Publicado: (2009)

Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial
por: Steele, Andrew Duncan, et al.
Publicado: (2012)

Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: Analysis of clinical trials of human rotavirus vaccine
por: Cheuvart, Brigitte, et al.
Publicado: (2014)

Incidence of rotavirus gastroenteritis by age in African, Asian and European children: Relevance for timing of rotavirus vaccination
por: Steele, A. Duncan, et al.
Publicado: (2016)

Immunogenicity of rotavirus vaccine (Rotarix(TM)) in infants with environmental enteric dysfunction
por: Mwape, Innocent, et al.
Publicado: (2017)

Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC
por: Debellut, Frédéric, et al.
Publicado: (2020)

Safety and reactogenicity of the combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b (DTPa-IPV/Hib) vaccine in healthy Vietnamese toddlers: An open-label, phase III study
por: Anh, Dang Duc, et al.
Publicado: (2015)

Quanty4RIXS: a program for crystal field multiplet calculations of RIXS and RIXS–MCD spectra using Quanty
por: Zimmermann, Patric, et al.
Publicado: (2018)

Effect of innate antiviral glycoproteins in breast milk on seroconversion to rotavirus vaccine (Rotarix) in children in Lusaka, Zambia
por: Mwila-Kazimbaya, Katayi, et al.
Publicado: (2017)

The evolving epidemiology of rotavirus A infection in Brazil a decade after the introduction of universal vaccination with Rotarix®
por: Carvalho-Costa, Filipe A., et al.
Publicado: (2019)

Rotarix in Japan: Expectations and Concerns
por: Nakagomi, Osamu, et al.
Publicado: (2011)

Evaluation of a new syringe presentation of reduced-antigen content diphtheria, tetanus, and acellular pertussis vaccine in healthy adolescents - A single blind randomized trial
por: Pavia-Ruz, Noris, et al.
Publicado: (2015)

Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception
por: Singh, Tina, et al.
Publicado: (2022)

Mr. William Howells Rix
Publicado: (1910)

Unorthodox branching ratios of the psi'''(4.414) as radial excitation of charmonium
por: Caichian, M, et al.
Publicado: (1978)

Correction to: Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception
por: Singh, Tina, et al.
Publicado: (2022)

Epidemiological trends for hospital admissions for acute rotavirus gastroenteritis in Belgium following the introduction of routine rotavirus vaccination and the subsequent switch from lyophilized to liquid formulation of Rotarix(™)
por: RAES, M., et al.
Publicado: (2016)

Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants
por: Lalwani, Sanjay K., et al.
Publicado: (2016)

A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison between Rotarix and RotaTeq Vaccines
por: van Hoek, Albert Jan, et al.
Publicado: (2012)

Comparative analysis of the Rotarix™ vaccine strain and G1P[8] rotaviruses detected before and after vaccine introduction in Belgium
por: Zeller, Mark, et al.
Publicado: (2017)

4414 Collagen Dermal Replacement Scaffold Mechanobiology in Treatment of Difficult-to-Heal Wounds
por: Sohutskay, David Oleh, et al.
Publicado: (2020)

Correction: A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison between Rotarix and RotaTeq Vaccines
por: van Hoek, Albert Jan, et al.
Publicado: (2012)

Comparative Analysis of G1P[8] Rotaviruses Identified Prior to Vaccine Implementation in Pakistan With Rotarix™ and RotaTeq™ Vaccine Strains
por: Sadiq, Asma, et al.
Publicado: (2020)

Corrigendum: Comparative Analysis of G1P[8] Rotaviruses Identified Prior to Vaccine Implementation in Pakistan With Rotarix™ and RotaTeq™ Vaccine Strains
por: Sadiq, Asma, et al.
Publicado: (2020)

Evaluation of ROTARIX(®) Booster Dose Vaccination at 9 Months for Safety and Enhanced Anti-Rotavirus Immunity in Zambian Children: A Randomised Controlled Trial
por: Laban, Natasha Makabilo, et al.
Publicado: (2023)

Maternal and Infant Histo-Blood Group Antigen (HBGA) Profiles and Their Influence on Oral Rotavirus Vaccine (Rotarix(TM)) Immunogenicity among Infants in Zambia
por: Chauwa, Adriace, et al.
Publicado: (2023)

Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b conjugate vaccine (DTPa-IPV/Hib) administered in Chinese infants
por: Li, Yanping, et al.
Publicado: (2016)

Real-time RT-PCR assays to differentiate wild-type group A rotavirus strains from Rotarix(®) and RotaTeq(®) vaccine strains in stool samples
por: Gautam, Rashi, et al.
Publicado: (2014)

IRIXS Spectrograph: an ultra high-resolution spectrometer for tender RIXS
por: Bertinshaw, Joel, et al.
Publicado: (2021)

Association between Immunogenicity of a Monovalent Parenteral P2-VP8 Subunit Rotavirus Vaccine and Fecal Shedding of Rotavirus following Rotarix Challenge during a Randomized, Double-Blind, Placebo-Controlled Trial
por: Fellows, Tamika, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c5ris0k14i4bpic18t80bofu23